2024
OR24-01 Time to Sperm Suppression With Daily Transdermal Use of Nestorone and Testosterone Combination Gel for Male Contraception Is Faster Than Expected
Gross D, Wang C, Page S, Sitruk-Ware R, Creinin M, Anderson R, Edelman A, Turok D, Kinuthia J, Vinay J, Barnhart K, Danielsson K, Mhlanga F, Fitzgerald C, Meriggiola C, Archer D, Lazorwitz A, Amory J, Swerdloff R, Bremner W, Lee M, Kroopnick J, Blithe D. OR24-01 Time to Sperm Suppression With Daily Transdermal Use of Nestorone and Testosterone Combination Gel for Male Contraception Is Faster Than Expected. Journal Of The Endocrine Society 2024, 8: bvae163.2435. PMCID: PMC12047133, DOI: 10.1210/jendso/bvae163.2435.Peer-Reviewed Original ResearchSperm suppressionWeek 8Male contraceptionCombination gelPhase IIb clinical trialDaily self-administrationTime to suppressionWeeks of treatmentFollow-up visitWeek 5Reversible male contraceptive methodsSperm concentration assessmentMale contraceptive methodsDaily skin applicationsSpermatogenic suppressionContraceptive efficacyHormone regimensEffective contraceptionHormonal agentsSelf-AdministrationInitial treatmentSegesterone acetateCo-administrationGel applicationTransdermal useComparative review of vasectomy guidelines and novel vasal occlusion techniques
Pelzman D, Honig S, Sandlow J. Comparative review of vasectomy guidelines and novel vasal occlusion techniques. Andrology 2024, 12: 1541-1546. PMID: 38774918, DOI: 10.1111/andr.13665.Peer-Reviewed Original Research
2023
Practice and development of male contraception: European Academy of Andrology and American Society of Andrology guidelines
Wang C, Meriggiola M, Amory J, Barratt C, Behre H, Bremner W, Ferlin A, Honig S, Kopa Z, Lo K, Nieschlag E, Page S, Sandlow J, Sitruk‐Ware R, Swerdloff R, Wu F, Goulis D. Practice and development of male contraception: European Academy of Andrology and American Society of Andrology guidelines. Andrology 2023, 12: 1470-1500. PMID: 37727884, DOI: 10.1111/andr.13525.Peer-Reviewed Original ResearchMale contraceptionContraceptive methodsClinical practiceNon-hormonal methodsLack of efficacyUnintended pregnancy ratesEvidence-based recommendationsMale contraceptive methodsAmerican SocietyMale contraceptive developmentAndrology (EAA) guidelinesConsensus guidelinesContraceptive efficacySurgical methodsHormonal methodsPregnancy rateContraceptive useGRADE systemOcclusion methodEuropean AcademySemen analysisReproductive risksContraceptionFamily planningEuropean Society
2018
Vasectomy
Pan S, Honig S. Vasectomy. 2018, 417-422. DOI: 10.1016/b978-0-12-801238-3.64934-6.Peer-Reviewed Original Research
2013
Sperm-specific ion channels: targets holding the most potential for male contraceptives in development
Zheng L, Wang H, Li B, Zeng X. Sperm-specific ion channels: targets holding the most potential for male contraceptives in development. Contraception 2013, 88: 485-491. PMID: 23845210, DOI: 10.1016/j.contraception.2013.06.002.Peer-Reviewed Original ResearchMeSH KeywordsAnoctamin-1Calcium ChannelsChloride Channel AgonistsChloride ChannelsContraceptive Agents, MaleDrugs, InvestigationalHumansIon ChannelsLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsLarge-Conductance Calcium-Activated Potassium ChannelsMaleMembrane ProteinsNeoplasm ProteinsOrgan SpecificityPotassium Channels, Voltage-GatedProtein SubunitsSignal TransductionSpermatozoa
2010
Update on Male Hormonal Contraception: Is the Vasectomy in Jeopardy?
Manetti G, Honig S. Update on Male Hormonal Contraception: Is the Vasectomy in Jeopardy? International Journal Of Impotence Research 2010, 22: 159-170. PMID: 20336073, DOI: 10.1038/ijir.2010.2.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply